I have read a little but may be missing something....
With all the blue sky "tests" being calculated aren't people forgetting that it is fundamental to FER that it has access to considerable dedicated time on a synchrotron (i imagine building one wouldn't make it past back of envelope cost calc.s).
I don't see where this has been ticked off - can someone answer?
Even with time being contracted the cost will be susbstantial. Tests for a 2000 trial are focussing on the results but the cost as well as time per test will be crucial. Forget all the calculations - until you find out if FER can get time to handle the possible tests out of, say, Kyoto, without spinning off numbers for the rest of the world.
FER presentation mentioned numbers around 1mill - is that the absolute max? When and where are they anticipating contracted time to be secured?
..
..
Discl: None. Watching.
My understanding is that one is being built in Melbourne, and there was talk of a dedicated beam for Fermiscan. Although I'm not sure how far this has advanced since this announcement. In any case, it is my understanding that there is not a problem posting off to the US for testing and results. I would need more time to read back for exact links to this too, but to my knowledge the MD seems satisfied by comments in the past of xray work being done o/s.
http://imagesignal.comsec.com.au/asxdata/20070604/pdf/00726930.pdf
The business
Fermiscan is commercialising a world-first, innovative test for the early detection of breast cancer using a simple, non-invasive screening method
• Scaleable business - significant economies as volumes grow
• Profitable business - EBITDA for 500,000 tests of AUD$ 61 million
• Huge global market - 100 million mammograms annually - in excess of 300 million women in South East Asia, Japan, Europe, USA, Australia
• Current synchrotron capacity enables more than 1 million tests per annum
• International licensing arrangements require minimal up front investment
• Commercial rollout in Australia & initial license territories by the end of 2007
• no further approvals required in Australia
• the Fermiscan breast cancer test will be launched as a “Pilot” in Australia in the second half of 2007
• Further clinical evaluation of prostate cancer, Alzheimer’s, other cancer and pathological states provides further opportunity
There are 40 synchrotrons located around the world
I have read a little but may be missing something....
Even with time being contracted the cost will be susbstantial. Tests for a 2000 trial are focussing on the results but the cost as well as time per test will be crucial. Forget all the calculations - until you find out if FER can get time to handle the possible tests out of, say, Kyoto, without spinning off numbers for the rest of the world.
FER presentation mentioned numbers around 1mill - is that the absolute max? When and where are they anticipating contracted time to be secured?
..
..
Discl: None. Watching.
South East Asia
Avia Reed International Pte Ltd granted rights to market and sell the Fermiscan test in:
• Singapore (1.7 M target population),
• Hong Kong (2.5 M)
• Malaysia (6.2 M)
• Thailand (20.5M)
• Vietnam (22.6 M)
• Indonesia (61.2M)
The management of Avia Reed International have had extensive medical experience, including ownership and management of medical centres, and pathology and outpatient clinics in Singapore
and another thing is that a synchrotron is only about $200mill
fermiscan could be able to build one in 5years....:
ok now i'm dreaming...
Go "FERmy" Go!
A pleasant surprise to day to see increased interest in our holdings.
If this momentum can keep going until the results come out (assuming they are A.O.K) we'll all be smiling.
Fermiscan's 2000 patient trial results should be completed very soon based on previous Company announcements. Despite the trial being behind schedule, all previous announcements relating to the actual results has been consistently very positive.
The stock price could get a huge spike if the final trial results are positive again. Considering Fermi's scientific breakthrough is a World First and involving a mainstream illness (Breast Cancer), it wouldn't be surprising if this is a takeover target by a large Pharmaceutical Company or Private Equity investor.
Any one agree or disagree?
Can't understand why the share price has gone down again. The good mail is that a positive announcement is iminent, either before or at the AGM. I honestly expected at least some smaller speculators to try and buy in.
Btw, when the positive announcement does arrive I hope Fermi's PR person does a better job than they have over the past 12 months. Considering Fermi has a Global breakthrough technology I think the Company deserves a lot more press than it has got. I've seen small time Companies in IT and Mining get 10 times more coverage despite having far less than Fermi. The PR manager is not very good at all in my humble opinion.
In a Country which is very familar with cancer due to suffering high profile celebrities such as Kylie Minogue, Delta Goodrum, Olivia Newton-John and Belinda Emmitt, you would think it wouldn't be that hard to leverage the awareness.
well now that grace entered fermiscan in the monthly stock competition
she will benefit from a low sp finisch today( last day of the month)
i'm sure she is behind this decline
also i been in the comp for the last 3 months with fer and always ended in the negative territory
but apart from that ... as also discussed on hot copper... no negetive news/input has been given to justify the decline in the sp
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?